Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2702484)

Published in Pediatr Clin North Am on June 01, 2009

Authors

Joyce M Koenig1, William J Keenan

Author Affiliations

1: Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Saint Louis University, Saint Louis, MO 63104, USA. koenijm@slu.edu

Articles citing this

Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis (2012) 1.22

Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. Emerg Infect Dis (2013) 1.06

Antimicrobial susceptibility among Gram-positive organisms collected from pediatric patients globally between 2004 and 2011: results from the Tigecycline Evaluation and Surveillance Trial. J Clin Microbiol (2013) 1.00

Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults. J Clin Microbiol (2011) 0.95

Group B Streptococcus and Streptococcus suis capsular polysaccharides induce chemokine production by dendritic cells via Toll-like receptor 2- and MyD88-dependent and -independent pathways. Infect Immun (2013) 0.92

Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. J Clin Microbiol (2010) 0.89

Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol (2012) 0.88

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum. Eur J Clin Microbiol Infect Dis (2012) 0.85

L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci. Infect Immun (2012) 0.85

Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun (2013) 0.84

Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis. J Perinatol (2014) 0.84

RovS and its associated signaling peptide form a cell-to-cell communication system required for Streptococcus agalactiae pathogenesis. MBio (2015) 0.81

How to optimize the evaluation and use of antibiotics in neonates. Pediatr Clin North Am (2012) 0.77

A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm. Eur J Clin Microbiol Infect Dis (2014) 0.77

Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. Front Immunol (2017) 0.76

Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B Streptococcus serotypes III and V. PLoS One (2014) 0.76

Antibiotic Therapy for Chorioamnionitis to Reduce the Global Burden of Associated Disease. Front Pharmacol (2017) 0.75

Draft Genome Sequence of Streptococcus agalactiae PR06. Genome Announc (2013) 0.75

Infections of the nervous system. Int J Crit Illn Inj Sci (2012) 0.75

Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing. J Perinatol (2016) 0.75

Articles cited by this

(truncated to the top 100)

NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI. N Engl J Med (1964) 7.19

Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01

Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep (2002) 6.51

Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13

Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet (2001) 5.56

Beta hemolytic streptococcus group B associated with problems of the perinatal period. Am J Obstet Gynecol (1961) 5.54

Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev (1998) 5.36

Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep (1996) 4.71

Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med (2002) 4.62

Group B beta hemolytic streptococcal meningitis in infants. J Pediatr (1973) 4.28

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med (1986) 3.96

Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood (2009) 3.90

Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71

Group B streptococcus. Lancet (1999) 3.41

Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics (1997) 3.01

Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA (1979) 3.00

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J (2005) 2.85

Group B streptococcal infections in elderly adults. Clin Infect Dis (2005) 2.59

Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis (1999) 2.50

Reverse vaccinology. Curr Opin Microbiol (2000) 2.36

Deaths in childbed from the eighteenth century to 1935. Med Hist (1986) 2.21

Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol (2006) 2.16

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis (1983) 2.14

Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN. J Exp Med (1935) 2.09

Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics (2008) 1.91

Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1996) 1.87

Group B Streptococcus and pregnancy: a review. Am J Obstet Gynecol (2008) 1.84

Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83

Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother (2005) 1.79

Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis (1983) 1.78

Group B streptococcal vaccines. Rev Infect Dis (1985) 1.74

Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics (2005) 1.74

Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr (1991) 1.68

Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed (1998) 1.64

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis (2009) 1.64

Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J (2004) 1.64

Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun (1994) 1.63

Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol (1989) 1.58

American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics (1992) 1.57

Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb Mortal Wkly Rep (2009) 1.56

Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr (1986) 1.55

Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. MMWR Morb Mortal Wkly Rep (2007) 1.54

ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol (2011) 1.53

Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47

Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review. Epidemiol Infect (2007) 1.43

Duration of antimicrobial prophylaxis for group B streptococcus in patients with preterm premature rupture of membranes who are not in labor. Am J Obstet Gynecol (2007) 1.41

Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics (2006) 1.41

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine (2003) 1.31

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis (1999) 1.30

Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust N Z J Obstet Gynaecol (1991) 1.25

Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr (1979) 1.24

Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis (1990) 1.24

Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis (2005) 1.24

A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol (1981) 1.23

Laboratory detection of group B Streptococcus for prevention of perinatal disease. Eur J Clin Microbiol Infect Dis (2004) 1.20

Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis (1985) 1.20

Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions. Cell Mol Life Sci (2005) 1.18

Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr (1980) 1.15

Deposition and degradation of C3 on type III group B streptococci. Infect Immun (1991) 1.15

Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J (2004) 1.11

Escherichia coli: a growing problem in early onset neonatal sepsis. Aust N Z J Obstet Gynaecol (2004) 1.07

Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatol (2004) 1.07

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis (2000) 1.07

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis (2004) 1.06

Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis (2006) 1.06

Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin (2008) 1.03

The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine (2005) 1.01

Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr Opin Microbiol (2006) 0.99

Defective oxidative metabolic responses of neutrophils from stressed neonates. J Pediatr (1981) 0.98

Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr Res (2005) 0.98

Extracellular virulence factors of group B Streptococci. Front Biosci (2004) 0.97

Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res (2004) 0.97

Real-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonates. Pediatrics (2006) 0.93

Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect (2006) 0.93

Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis (1986) 0.92

Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev (2004) 0.91

Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics (2002) 0.91

Spontaneous and Fas-mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils. J Leukoc Biol (1998) 0.88

Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. Rev Infect Dis (1990) 0.88

Oxygen regulates invasiveness and virulence of group B streptococcus. Infect Immun (2003) 0.88

Antimicrobial defenses in the neonate. Semin Perinatol (1990) 0.87

Type III group B Streptococcus: functional interaction with IgG subclass antibodies. J Infect Dis (1987) 0.87

Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun (1995) 0.87

Experimental group B streptococcal infection in the rhesus monkey. I. Disease production in the neonate. Am J Obstet Gynecol (1978) 0.87

Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci. Infect Immun (1993) 0.86

Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. Eur J Obstet Gynecol Reprod Biol (1991) 0.86

The role of complement in opsonization of GBS. Antibiot Chemother (1971) (1985) 0.83

Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics (1999) 0.82

The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study. Arch Gynecol Obstet (2006) 0.82

Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. Paediatr Perinat Epidemiol (2007) 0.81

Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr Res (1983) 0.81

Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med (2009) 0.81

Fatal early onset group B streptococcal sepsis with normal leukocyte counts. Pediatr Infect Dis (1985) 0.80

ON THE GERM THEORY. Science (1881) 0.79

No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol (2005) 0.79